Skip to main content
Displaying 1171 of 2857 articles.

How antibody therapy impacts COVID vaccines

People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.

Research on rare genetic disease sheds light on a common head and neck cancer

Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.

Cancer stem cells are fueled through dialogue with their environments

The findings suggest that many of the mutations in cancer may simply be setting in stone a path already forged by the tumor stem cell’s aberrant dialogue with its surroundings.

Ant pupae secrete fluid as "milk" to nurture young larvae

This newly discovered “social fluid” appears to unite ant colonies across developmental stages into one superorganism.

Promising new drug target for a rare liver cancer

Fibrolamellar carcinoma needs one specific mutation in order to thrive, and impeding it reduces tumor growth in mice.

New evidence of biochemical states and force working in concert

When an actin filament bends during cell movement, older actin deforms differently than newer actin, allowing regulatory proteins to tell the two states apart.

Mathematical modeling suggests counties are still unprepared for COVID spikes

If jurisdictions plan to share resources in advance, the study concludes, this could prevent one rare event from overwhelming a county or state.

Why some people are mosquito magnets

The female mosquito will hunt down any human, but some of us get bitten far more than others. The answer why may be hidden in our skin.

The brain cells that slow us down when we're sick

New study pinpoints the cluster of neurons that tell mice to eat, drink, and move around less when they're fighting bacterial infections.  

Common mutation linked to COVID mortality

Because three percent of the world population possesses these gene variants, the findings may have implications for hundreds of millions of individuals around the world.

Unlocking the mystery of how mosquitoes smell humans

Through questioning their assumptions about how mosquitoes sense and interpret odors, scientists may have discovered why efforts to throw the vectors of dengue and Zika off the human scent have not succeeded.

Ant colonies behave like neural networks when making decisions 

Colonies decide to flee rising temperatures in much the same way that neural computations give rise to decisions.

How the intestine replaces and repairs itself

A new study suggests that stem cells are able to integrate cues from their surroundings and coordinate their behavior across tissue through networks of vasculature in their close vicinity.

Colorectal cancer tumors both helped and hindered by T cells

Researchers have long disagreed over whether 𝛄𝛅T cells in the gut promote or discourage tumor growth, but new evidence suggests they have the capacity to do both.

New study reveals where memory fragments are stored

The research demonstrates the distributed nature of memory processing in the brain, and reveals a dedicated pathway for memory recall, which is less understood than memory formation.

A third vaccine dose may increase protection from Omicron

The booster appears to galvanize memory B cells into producing potent and versatile antibodies that neutralize both the original virus and its many variants.

How intricate patterns arise in developing tissues

In developing bird skin, immature cells move around and form intricate patterns. Scientists are zeroing in on the mechanical forces guiding the process.

>

Building a human ‘pangenome’ to capture global genomic diversity

The human reference genome, the most widely used resource in human genetics, is getting a major update.

Hundreds of new drug targets to combat tuberculosis

The study highlights genes that, when silenced, render Mycobacterium tuberculosis vulnerable to antibiotics, and identifies existing drugs that may be effective against one prominent strain.

One protein's surprising partnership with single-stranded DNA

Linker histone H1 appears capable of distinguishing between single-stranded and double-stranded DNA, suggesting that its role in maintaining our genomes extends far beyond that of keeping chromosomes compact.

A synthetic antibiotic may help turn the tide against drug-resistant bacteria

The compound attacks MRSA, C. diff, and several other deadly pathogens. Its discovery demonstrates the power of combining computational biology, genetic sequencing, and synthetic chemistry to study bacterial evolution.

The genetic underpinnings of severe staph infections

A mutated gene may explain why some Staphylococcus aureus infections turn lethal, a finding with significant implications for people living with 5p- syndrome.

>

Antibody therapy controls HIV for months in new clinical trial

Unlike conventional antiretroviral drugs, treatment with broadly neutralizing antibodies does not rely on vigilant daily dosing and could potentially reduce the body’s reservoir of latent viruses.

How a narrow-spectrum antibiotic takes aim at C. diff

A new study reveals how the drug fidaxomicin selectively targets a dangerous pathogen without causing harm to beneficial bacteria. The findings could inform the development of new narrow-spectrum antibiotics for treating other types of infection.

The human genome is, at long last, complete

Even after 20 years of upgrades, eight percent of the human genome was still left unsequenced and unstudied. Until now.

How bacteria "self-vaccinate" against viral invaders

In studying how bacteria respond to viral infection, scientists are learning that their defense strategies cooperate in ways reminiscent of the elaborate immune systems of animals.

Scientists discover new mechanism involved in learning and memory

FMRP, a protein whose loss causes intellectual disability, may regulate a neuron's synaptic response by establishing a feedback loop between the cell's nucleus and its faraway dendrites.

Insights into a cystic fibrosis treatment may herald a novel class of drugs 

Protein folding diseases, from Alzheimer's to Gaucher's, may one day be treated by a unique class of protein corrector molecules that are already helping manage cystic fibrosis.  

>

New comprehensive map of the portal to the cell’s nucleus

The findings, which may have implications for a wide range of human diseases, suggest that nuclear pore complexes vary in structure and function even within a single nucleus.

A novel compound might defeat multidrug-resistant bacteria common in hospitals

Increasingly, hospitalized patients contract infections that evade current antibiotics including colistin, long used as a last treatment option. The discovery of a new colistin variant might make it possible to outmaneuver these pathogens.